Michele Cavo

Michele Cavo

UNVERIFIED PROFILE

Are you Michele Cavo?   Register this Author

Register author
Michele Cavo

Michele Cavo

Publications by authors named "Michele Cavo"

Are you Michele Cavo?   Register this Author

100Publications

2961Reads

32Profile Views

Understanding mortality in multiple myeloma: Findings of a European retrospective chart review.

Eur J Haematol 2019 Aug 18;103(2):107-115. Epub 2019 Jun 18.

Department of Haematology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13264DOI Listing
August 2019

Successful Employment of Brentuximab Vedotin in a Patient Undergoing Hemodialysis: The First Real-life Experience.

Clin Lymphoma Myeloma Leuk 2019 Aug 30. Epub 2019 Aug 30.

Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.07.443DOI Listing
August 2019

Facing lenalidomide-refractory myeloma.

Authors:
Michele Cavo

Blood 2019 Jul;134(2):99-101

Bologna University School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2019-04-901157DOI Listing
July 2019

Spontaneous remission of follicular lymphoma.

Hematol Oncol 2019 Jul 23. Epub 2019 Jul 23.

Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2653DOI Listing
July 2019

Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature.

Mycoses 2019 Jul 31. Epub 2019 Jul 31.

Unit of Infectious Diseases, Department of Medical and Surgical Sciences, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/myc.12978DOI Listing
July 2019

Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.

Br J Haematol 2019 Jun 18;185(5):987-991. Epub 2018 Nov 18.

Institute of Haematology "L. e A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15682DOI Listing
June 2019

Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016.

Br J Haematol 2019 Jun 22;185(5):981-984. Epub 2018 Nov 22.

Department of Haematology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15680DOI Listing
June 2019

Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies.

J Infect 2019 Jun 8;78(6):484-490. Epub 2019 Apr 8.

Clinic of Infectious Diseases, Department of Medical and Surgical Sciences, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01634453193011
Publisher Site
http://dx.doi.org/10.1016/j.jinf.2019.04.002DOI Listing
June 2019

A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies.

Hematol Oncol 2019 Apr 30;37(2):202-204. Epub 2019 Jan 30.

Institute of Hematology "L. e A. Seràgnoli,", University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2573DOI Listing
April 2019

Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients.

Br J Haematol 2019 Feb 8;184(3):424-430. Epub 2018 Nov 8.

Institute of Haematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.15668
Publisher Site
http://dx.doi.org/10.1111/bjh.15668DOI Listing
February 2019

Imaging in multiple myeloma: How? When?

Blood 2019 02 26;133(7):644-651. Epub 2018 Dec 26.

"Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-08-825356DOI Listing
February 2019

Hodgkin lymphoma presenting with paraneoplastic myasthenia: a case report.

Leuk Lymphoma 2018 12 4;59(12):2990-2993. Epub 2018 Apr 4.

a Institute of Hematology "L. e A. Seràgnoli", University of Bologna , Bologna , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1443336DOI Listing
December 2018

Treatment optimization for multiple myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in and models.

Haematologica 2018 12 19;103(12):e602-e606. Epub 2018 Jul 19.

"L. & A. Seràgnoli" Institute of Haematology, Department of Experimental Diagnostic and Specialty Medicine (DIMES), Bologna University School of Medicine, Italy.

View Article

Download full-text PDF

Source
http://www.haematologica.org/lookup/doi/10.3324/haematol.201
Publisher Site
http://dx.doi.org/10.3324/haematol.2017.186924DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269297PMC
December 2018

Extramedullary metastatic plasmacytoma in multiple myeloma.

G Ital Dermatol Venereol 2018 Oct 16;153(5):741-743. Epub 2017 Nov 16.

Unit of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0392-0488.17.05687-5DOI Listing
October 2018

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.

Stem Cell Res Ther 2018 10 25;9(1):271. Epub 2018 Oct 25.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. & A. Seràgnoli", University of Bologna, Azienda Ospedaliero-Universitaria Policlinico S. Orsola-Malpighi Bologna, Via Massarenti 9, 40138, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13287-018-1013-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202844PMC
October 2018

Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review.

Support Care Cancer 2018 Jul 20;26(7):2075-2090. Epub 2018 Mar 20.

Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Via Benevento, 6, 00161, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4137-xDOI Listing
July 2018

Anti-CD38 and anti-SLAMF7: the future of myeloma immunotherapy.

Expert Rev Hematol 2018 05 27;11(5):423-435. Epub 2018 Mar 27.

a "Seràgnoli" Institute of Hematology , Bologna University School of Medicine , Bologna , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474086.2018.1
Publisher Site
http://dx.doi.org/10.1080/17474086.2018.1456331DOI Listing
May 2018

Bones in Multiple Myeloma: Imaging and Therapy.

Am Soc Clin Oncol Educ Book 2018 May;38:638-646

From the "Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy; Washington University School of Medicine, St. Louis, MO; Indiana University Simon Cancer Center, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_205583DOI Listing
May 2018

Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience.

Clin Lymphoma Myeloma Leuk 2018 04 16;18(4):297-299. Epub 2018 Feb 16.

Institute of Hematology "Lorenzo e Ariosto Seràgnoli", University of Bologna, Bologna, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.02.007DOI Listing
April 2018

The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mould disease in patients with haematological malignancies.

Br J Radiol 2018 Feb 10;91(1083):20170220. Epub 2018 Jan 10.

1 Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Division of Radiology, S.Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20170220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965459PMC
February 2018

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.

N Engl J Med 2018 02 12;378(6):518-528. Epub 2017 Dec 12.

From University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca (M.-V.M.), and Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona (J.S.-M.) - both in Spain; National and Kapodistrian University of Athens, Athens (M.A.D.); the Institute of Hematology, Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna (M. Cavo), and Azienda Ospedaliera "Santa Maria," Terni (A.M.L.) - both in Italy; Japanese Red Cross Medical Center, Department of Hematology, Tokyo (K.S.); University of Chicago Medical Center, Chicago (A.J.); Würzburg University Medical Center, Würzburg, Germany (S.K.); Université Catholique de Louvain (UCL), Centre Hospitalier Universitaire UCL Namur, Yvoir (C.D.), and Janssen Research and Development, Beerse (W.D.) - both in Belgium; Champalimaud Center for the Unknown, Lisbon, Portugal (P.L.); Semmelweis Egyetem, Budapest, Hungary (Z.N.); Dnepropetrovsk City Clinical Hospital #4, Dnepropetrovsk, Ukraine (P.K.); University Hospital Brno, Brno, Czech Republic (L.P.); University Hospitals Birmingham NHS Foundation Trust, Birmingham (M. Cook), and Leicester Royal Infirmary-Haematology, Leicester (M.G.) - both in the United Kingdom; the Department of Cancer Prevention, School of Public Health, Silesian Medical University, Katowice, Poland (S.G.); Clínica de Tratamento E, Cuiaba, Brazil (A.C.); Andrew Love Cancer Centre, Geelong, VIC, Australia (P.C.); Clinic of Professional Pathology, Saratov, Russia (T.S.); the Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea (S.-S.Y.); LTD "Medinvent" Institute of Health, Tbilisi, Georgia (G.I.); Matsuyama Red Cross Hospital, Matsuyama, Japan (T.F.); Janssen Research and Development, Spring House, PA (C.C., R.C., W.C., M.Q.); and Janssen Research and Development, Raritan, NJ (J.W., H.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1714678DOI Listing
February 2018

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy.

Mol Cancer 2018 02 19;17(1):49. Epub 2018 Feb 19.

Hematology/Oncology "L. e A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-018-0780-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817796PMC
February 2018

Retreatment and prolonged therapy with subcutaneous bortezomib in patients with relapsed multiple myeloma: A randomized, controlled, phase III study.

Eur J Haematol 2018 Jan 30;100(1):10-19. Epub 2017 Oct 30.

Seràgnoli Institute of Hematology, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12937DOI Listing
January 2018

Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.

Mycoses 2018 Jan 22;61(1):53-60. Epub 2017 Sep 22.

Institute of Hematology "Lorenzo e Ariosto Seràgnoli", Department of Specialistic Diagnostic and Experimental Medicine (DIMES), Sant'Orsola-Malpighi Hospital Teaching Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/myc.12697
Publisher Site
http://dx.doi.org/10.1111/myc.12697DOI Listing
January 2018

FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.

J Cell Biochem 2017 11 30;118(11):3968-3975. Epub 2017 May 30.

Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Institute of Hematology L. and A. Seràgnoli-University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.26052DOI Listing
November 2017

Valosin-Containing Protein/p97 as a Novel Therapeutic Target in Acute Lymphoblastic Leukemia.

Neoplasia 2017 Oct 29;19(10):750-761. Epub 2017 Aug 29.

Department of Hematology and Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Cancer Science Institute of Singapore, National University of Singapore, Singapore; National University Cancer Institute of Singapore, National University Hospital, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2017.08.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576979PMC
October 2017

The More, The Better: "Do the Right Thing" For Natural Killer Immunotherapy in Acute Myeloid Leukemia.

Front Immunol 2017 19;8:1330. Epub 2017 Oct 19.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology L. and A. Seràgnoli, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fimmu.2017.01
Publisher Site
http://dx.doi.org/10.3389/fimmu.2017.01330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653691PMC
October 2017

Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemia.

Oncotarget 2017 Oct 22;8(50):88244-88250. Epub 2017 Sep 22.

Department of Experimental Diagnostic and Specialty Medicine, DIMES-Institute of Hematology "L. and A. Seràgnoli", University of Bologna Medical School, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21166DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675707PMC
October 2017

Retrospective Cohort Analysis of Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological Malignancies.

Antimicrob Agents Chemother 2017 09 24;61(9). Epub 2017 Aug 24.

Unit of Infectious Diseases, Policlinico Sant'Orsola-Malpighi, Department of Medical Sciences and Surgery, University of Bologna, Bologna, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.02651-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571305PMC
September 2017

The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.

BMC Cancer 2017 Aug 5;17(1):523. Epub 2017 Aug 5.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Via Massarenti, 9-40138, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3511-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545087PMC
August 2017

A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?

AJR Am J Roentgenol 2017 Jul 18;209(1):152-158. Epub 2017 Apr 18.

2 Diagnostic and Interventional Radiology, The "Rizzoli" Orthopaedic Institute, Via G. C. Pupilli 1, 40136 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.16.17219DOI Listing
July 2017

Toward a GEP-based PET in myeloma.

Blood 2017 07;130(1):2-3

BOLOGNA UNIVERSITY SCHOOL OF MEDICINE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-05-781278DOI Listing
July 2017

Mutations in and genes are associated with specific alterations of the immune system in myelofibrosis.

Oncoimmunology 2017 5;6(10):e1345402. Epub 2017 Jul 5.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1345402DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665081PMC
July 2017

The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study.

Oncotarget 2017 Jun;8(23):37239-37249

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology 'L. and A. Seràgnoli', University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.16744DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514906PMC
June 2017

Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents.

Haematologica 2017 03 1;102(3):e104-e107. Epub 2016 Dec 1.

"Seràgnoli" Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, Bologna University School of Medicine, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.154070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394964PMC
March 2017

Radiologic findings of Fusarium pneumonia in neutropenic patients.

Mycoses 2017 Feb 29;60(2):73-78. Epub 2016 Jul 29.

Division of Radiology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/myc.12538DOI Listing
February 2017

Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients.

Am J Hematol 2017 Jan 12;92(1):37-41. Epub 2016 Nov 12.

Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Institute of Hematology and Clinical Oncology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24572DOI Listing
January 2017

The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.

Oncotarget 2017 Jan;8(2):2261-2274

Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356797PMC
January 2017

Inverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for multiple myeloma.

BMC Med Res Methodol 2016 11 9;16(1):150. Epub 2016 Nov 9.

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via Maroncelli 40, 47014, Meldola, FC, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12874-016-0253-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103416PMC
November 2016

Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly.

Mediators Inflamm 2016;2016:5860657. Epub 2016 Sep 8.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/5860657DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031875PMC
September 2016